Minnetronix Medical Recognized for Surgical Technology Innovation in 2021 MedTech Breakthrough Awards Program
St. Paul, MN—Minnetronix Medical, Inc., a leading medical technology partner to global medical device companies, today announced that its MindsEye™ Expandable Port has won the “Best New Technology Solution – Surgical” award in the fifth annual MedTech Breakthrough Awards program. The program is conducted by MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies and products in the global health and medical technology market.
The MindsEye™ Expandable Port is the first minimally invasive, expandable port designed for use in the treatment of stroke, cancer, and other conditions. The device’s dynamic retraction creates a custom-sized channel allowing neurosurgeons to reach target areas deep within the brain. This next-generation deep brain access technology minimizes invasiveness to brain tissue and allows surgeons to work without unnecessary distractions.
“Managing risks in neurocritical care is a complex business, with secondary injury as a critical potential complication. We’re developing therapeutic solutions to keep neurosurgeons ahead of secondary injury, enabling better outcomes in neurocritical patients,” said Jeremy Maniak, Minnetronix CEO. “The MindsEye™ Port is next-generation technology. Given its unique features, the port has already attracted interest among neurosurgeons and potential distribution partners,” he added. “We are honored to receive this 2021 MedTech Breakthrough Award. This is a testament to the hard work and dedication of the entire Minnetronix Medical team.”
The mission of the MedTech Breakthrough Awards is to honor excellence and recognize the innovation, hard work and success in a range of health and medical technology categories, including Robotics, Clinical Administration, Telehealth, Patient Engagement, Electronic Health Records (EHR), mHealth, Medical Devices, Medical Data and many more. This year’s program attracted more than 3,850 nominations from over 17 different countries throughout the world.
“The complexity of neurocritical care means unforeseen challenges are inevitable, and MindsEye helps reduce procedural risk in addressing these challenges, as well as enabling earlier intervention, accelerated healing, and improving overall quality of life for patients,” said James Johnson, managing director, MedTech Breakthrough. “Congratulations to Minnetronix Medical for this incredible piece of technology that will save lives. We’re thrilled to present you with this 2021 MedTech Breakthrough Award.”